Hypermethylation of glutatione-s-transferasi (GSTP1) as plasmatic molecular biomarker for prostate cancer WCRJ 2014; 1 (4): e403
Radiochemotherapy for unresectable glioblastoma multiforme: a mono-institutional experience WCRJ 2014; 1 (4): e401
A cost-effectiveness method for the enrichments of minority mutant DNA in a large excess of wild type DNA. Detection of B-RAF 1799T>A (V600E) mutations in the thyroid fine needle aspirate WCRJ 2014; 1 (4): e399
Liver MRI in oncological patients: what benefits can we get? A practical minireview WCRJ 2014; 1 (4): e397
Gastric cancer: prognostic aspects, predictive factors to therapy response and real impact on treatment approach WCRJ 2014; 1 (4): e395
Current status and perspectives of AIDS-related Kaposis’s sarcoma in the c-ART era WCRJ 2014; 1 (4): e393
Pharmacogenetic based drug-drug interactions between Highly Active Antiretroviral Therapy (HAART) and antiblastic chemotherapy WCRJ 2014; 1 (4): e386